FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

788026004: Antiprotozoal therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3778479015 Antiprotozoal therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3778480017 Antiprotozoal therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antiprotozoal therapeutic role Is a Antiparasitic therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Antimalarial therapeutic role Is a True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Medicinal product acting as antiprotozoal agent (product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing acetarsol Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Acetarsol Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing atovaquone Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only atovaquone in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely atovaquone 150 milligram/1 milliliter conventional release oral suspension Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing atovaquone in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Atovaquone Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing nimorazole Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only nimorazole (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing nitazoxanide Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only nitazoxanide in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Nitazoxanide Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nitazoxanide 20 milligram/1 milliliter conventional release oral suspension Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nitazoxanide 500 milligram/1 each conventional release oral tablet Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing nitazoxanide in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Secnidazole Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only secnidazole in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing secnidazole Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing secnidazole in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol in otic dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only betamethasone and clioquinol in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clioquinol and flumetasone in otic dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clioquinol and hydrocortisone in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clioquinol in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clioquinol in otic dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clioquinol (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Flumetasone + Clioquinol Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clioquinol and fluocinolone (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Hydrocortisone + Clioquinol Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clioquinol 10 milligram/1 milliliter and flumetasone pivalate 200 microgram/1 milliliter conventional release ear drops Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing betamethasone and clioquinol Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol and hydrocortisone Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing ascorbic acid and clioquinol Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing calamine and clioquinol and zinc oxide Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol and fluocinolone Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol and flumetasone Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol and flumetasone in otic dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol and hydrocortisone in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only ascorbic acid and clioquinol (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Betamethasone + Clioquinol Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Zinc oxide + Calamine + Clioquinol Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing emetine Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only emetine (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing melarsoprol Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing melarsoprol in parenteral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only melarsoprol in parenteral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only melarsoprol (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing miltefosine Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing miltefosine in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only miltefosine in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Miltefosine Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely miltefosine 10 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely miltefosine 50 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing eflornithine Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing eflornithine in parenteral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only eflornithine in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only eflornithine in parenteral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Eflornithine Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely eflornithine (as eflornithine hydrochloride monohydrate) 115 milligram/1 gram conventional release cutaneous cream (clinical drug) Plays role False Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely eflornithine (as eflornithine hydrochloride) 139 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing eflornithine in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing benznidazole Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing benznidazole in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only benznidazole in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Benznidazole Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benznidazole 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benznidazole 12.5 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing nifurtimox Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing nifurtimox in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only nifurtimox in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Nifurtimox Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing suramin in parenteral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only suramin (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only suramin in parenteral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing suramin Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing sodium stibogluconate Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing sodium stibogluconate in parenteral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Sodium stibogluconate Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only sodium stibogluconate in parenteral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sodium stibogluconate 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing nitrofural Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only nitrofural in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only nitrofural (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nitrofural 2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing nitrofural in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing pentamidine in parenteral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing pentamidine Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing pentamidine in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Pentamidine Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only pentamidine in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only pentamidine in parenteral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only pentamidine in pulmonary dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier

Page 1 of 3 Next End

This concept is not in any reference sets

Back to Start